...
【24h】

Varicella Vaccine—Where Are We?

机译:水痘疫苗—我们在哪里?

获取原文
           

摘要

Varicella is a disease of children that was differentiated clinically from smallpox about 200 years ago. It is now known to be a herpesvirus. The relationship of varicella to zoster was first described by Von Bokay.1 He postulated that both were caused by the same agent when he noted that chickenpox frequently followed exposure to zoster. That a single agent was responsible for both conditions was confirmed by Weller and Stoddard2 who first propagated virus from patients with varicella and zoster in cell cultures; they3 subsequently demonstrated that the antibody produced following zoster or varicella reacted with the same antigen. Indeed, Brunell and his co-workers4 were able to show that globulin extracted from the serum of patients with zoster protected exposed children from varicella.In 1974, Takahashi and his colleagues5 published the first report of his chickenpox vaccine. They found that normal children were protected against infection if the vaccine was given prior to or even three days following exposure; the vaccine was essentially devoid of side effects. Subsequently, Izawa et al6 tested the vaccine in children with leukemia, demonstrating both its safety and effectiveness. Many investigators have confirmed the observations of those investigators during the ensuing 10 years.This experience must now be used to determine whether and how live varicella vaccine should be used (1) in children with leukemia, (2) universally in normal children, and (3) in susceptible adults.The reticence to use the vaccine in normal children has been because of the lack of experience with live herpesvirus vaccines.7
机译:水痘是一种儿童疾病,大约200年前在临床上与天花区别开来。现在已知是疱疹病毒。水痘与带状疱疹的关系最早由冯·博凯(Von Bokay)描述。1当他指出水痘经常随带状疱疹暴露后,两者都由同一病原体引起。 Weller和Stoddard2证实了由单一药物引起这两种情况,他们首先在细胞培养物中从水痘和带状疱疹患者中繁殖出病毒。他们随后证实带状疱疹或水痘后产生的抗体与相同抗原反应。实际上,布鲁内尔及其同事[4]能够证明从带状疱疹患者血清中提取的球蛋白可以保护暴露的水痘儿童。1974年,高桥及其同事5发表了他的水痘疫苗的首次报告。他们发现,如果在接触前或接触后三天接种疫苗,正常儿童可以免受感染。该疫苗基本上没有副作用。随后,Izawa等[6]在白血病儿童中测试了该疫苗,证明了其安全性和有效性。在接下来的10年中,许多研究人员已经证实了这些研究人员的观察结果,现在必须利用这一经验来确定是否应以及如何使用活水痘疫苗(1)在白血病儿童中;(2)在普通儿童中普遍使用;以及( 3)在易感的成年人中。由于缺乏活疱疹病毒疫苗的经验,因此在正常儿童中不愿使用疫苗。7

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号